Supernus Pharmaceuticals
SUPN
SUPN
223 hedge funds and large institutions have $1.42B invested in Supernus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 83 increasing their positions, 83 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 228 → 223 (-5)
13% less capital invested
Capital invested by funds: $1.64B → $1.42B (-$219M)
35% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $2.36M
Holders
223
Holding in Top 10
3
Calls
$1.54M
Puts
$2.36M
Top Buyers
| 1 | +$7.06M | |
| 2 | +$6.98M | |
| 3 | +$5.51M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.26M |
| 5 |
Renaissance Technologies
New York
|
+$4.44M |
Top Sellers
| 1 | -$9.99M | |
| 2 | -$7.92M | |
| 3 | -$7.02M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.24M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.74M |